| APC | antigen presenting cell |
| Arg-1 | arginine-1 |
| CAA | cancer-associated adipocytes |
| CAF | cancer-associated fibroblast |
| CAR | chimeric antigen receptor |
| cDC | conventional DC |
| CSC | cancer stem cell |
| CTLA-4 | cytotoxic T lymphocyte antigen 4 |
| DC | dendritic cell |
| EC | endothelial cell |
| ECM | extracellular matrix |
| EGF | epidermal growth factor |
| EMT | epitelial-mesenchymal transition |
| eTreg | effector/activated T reg |
| EV | extracellular vesicle |
| FGF | fibroblast growth factor |
| GITR | glucocorticoid-induced TNFR-related protein |
| GM-CSF | granulocyte-macrophage colony stimulating factor |
| G-MDSC | granulocitic myeloid-derived suppressor cell |
| HER2 | human epidermal growth factor receptor 2 |
| ICI | immune checkpoint inhibitor |
| IDO1 | indoleamine 2,3-dioxygenase 1 |
| IGF | insulin-like growth factor |
| IL | interleukin |
| IFN | interferon |
| MDSC | myeloid-derived suppressor cell |
| M-MDSC | monocytic-myeloid-derived suppressor cell |
| MMP | matrix metalloproteinase |
| mo-DC | monocytes |
| mRCC | metastatic renal cell carcinoma |
| MSC | mesenchymal stem cells |
| NK | natural killer |
| NO | nitric oxide |
| NSCLC | non-small-cell lung cancer |
| ORR | overall response rate |
| OS | overall survival |
| PD-1 | programmed cell death 1 |
| pDC | plasmacytoid DC |
| PDGF-β | platelet-derived growth factor-beta |
| PD-L1 | programmed cell death ligand 1 |
| PGE-2 | prostaglandin E-2 |
| PMN | pre-metastatic niche |
| PMN-MDSC | polymorphonuclear MDSC |
| ROS | reactive oxygen species |
| RR | response rate |
| SR | survival rate |
| TAA | tumor associated antigens |
| TAM | tumor-associated macrophage |
| TCR | T cell receptor |
| TGF-β | transforming growth factor-beta |
| TIL | tumor-infiltrating lymphocytes |
| TME | tumor microenvironment |
| TNF-α | tumor necrosis factor-alfa |
| Treg | regulatory T cell |
| VEGFA | vascular endothelial growth factor A |